Medicare Enrolled

Dr. Marilin Espino-Maya, MD

Nuclear Medicine · Spring Hill, FL
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
10461 QUALITY DR, Spring Hill, FL 34609
8132515822
In practice since 2006 (20 years)
NPI: 1659330033 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Espino-Maya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Espino-Maya? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Espino-Maya

Dr. Marilin Espino-Maya is a nuclear medicine in Spring Hill, FL, with 20 years in practice. Based on federal Medicare data, Dr. Espino-Maya performed 3,650 Medicare services across 2,052 unique beneficiaries.

Between the years covered by Open Payments, Dr. Espino-Maya received a total of $122 from 1 pharmaceutical and/or device company across 1 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Espino-Maya is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 48% volume in FL$ $122 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,650
Medicare services
Top 48% in FL for nuclear medicine
2,052
Unique beneficiaries
$317
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~182 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)860$0$1
Nuclear medicine study from skull base to mid-thigh with ct scan412$1,036$7,052
Chest X-ray, 1 view391$7$139
Piflufolastat f-18, diagnostic, 1 millicurie367$465$605
Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie364$776$1,005
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries309$328$427
Nuclear medicine study of parathyroid87$29$563
X-ray of abdomen, 1 view80$7$139
Nuclear medicine studies of heart muscle at rest and with stress and spect73$59$1,183
Nuclear medicine study whole body with ct scan64$1,131$7,508
Chest X-ray, 2 views60$8$162
Nuclear medicine study of lung circulation48$27$477
Injection, furosemide, up to 20 mg41$0$9
Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging32$53$394
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries30$29$40
CT scan of head/brain, without contrast28$30$504
Nuclear medicine study of lymphatic system26$43$833
CT scan of chest, without contrast23$104$796
Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries23$245$350
Nuclear medicine study of bone and/or joint whole body22$186$692
Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries22$2,136$2,750
Imaging for evaluation of swallowing function21$20$255
Nuclear medicine study of stomach to assess emptying21$229$729
Nuclear medicine study of kidney, blood, flow, and function with drug administration21$133$649
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging21$268$855
Nuclear medicine study, spect imaging, at least 2 areas or separate acquisitions, single day imaging, or single area or acquisition over multiple days21$66$358
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries21$57$90
Bone density scan (DEXA)20$36$295
Low dose ct scan of chest for lung cancer screening18$134$678
Nuclear medicine study of liver and bile duct system16$27$526
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries14$7$75
Shoulder X-ray, 2+ views13$8$143
Injection, sincalide, 5 micrograms13$92$175
Nuclear medicine study of liver and bile duct system with use of drugs12$300$866
Ultrasound study of one arm or leg veins with compression and maneuvers12$17$418
Ct scan of blood vessels of chest with contrast11$68$1,316
Hip X-ray, 2-3 views11$8$212
X-ray of lower leg, 2 views11$6$110
Technetium tc-99m sestamibi, diagnostic, per study dose11$54$79
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$122
Total received (2024-2024)
Bottom 36% in FL for nuclear medicine
1
Company
1
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$122 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$122

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PROGENICS PHARMACEUTICALS, INC.
$122
Top 3 companies account for 100.0% of total payments
Associated products mentioned in payments ›
PYLARIFY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for a nuclear medicine in Spring Hill?
Compare nuclear medicines in the Spring Hill area by procedure volume, costs, and industry payment transparency.
Browse nuclear medicines nearby

Geographic Context

Nuclear Medicines within 10 mi
3
Per 100K population
1.5
County median income
$63,193
Nearest hospital
SPRINGBROOK HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Espino-Maya is a cardiac imaging specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Espino-Maya experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Espino-Maya performed 860 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Espino-Maya receive payments from pharmaceutical companies?
Yes. Dr. Espino-Maya received a total of $122 from 1 company across 1 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Espino-Maya's costs compare to other nuclear medicines in Spring Hill?
Dr. Espino-Maya's average Medicare payment per service is $317. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Espino-Maya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →